👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Kate Stringaris
Haematology
English
11,473+
Patients seen
2
Years in practice
9
Publications
1
Languages spoken
About
Dr Kate Stringaris is a Consultant Haematologist and Clinician Scientist at University College London Hospital, specialising in the treatment of blood disorders through chemotherapy, cellular therapies, and stem cell transplantation.
She obtained her medical degree from University College London and completed her general medical training at St George's Hospital. Her specialist haematology training took place at the Royal Free Hospital and Hammersmith Hospitals in London. Dr Stringaris earned a PhD in Leukaemia from Imperial College London and previously served as a Senior Clinical Lecturer at St Bart’s Hospital.
Her research focuses on immune deficiencies in leukaemia and transplantation immunology. She spent four years as a senior research physician at the National Heart, Lung, and Blood Institute, National Institutes of Health (USA), where she explored natural killer cell immunity and innovative immune therapies for acute myeloid leukaemia.
Appointed as a Consultant Haematologist in 2014, Dr Stringaris is committed to advancing haematology through clinical practice and research. Her expertise includes chemotherapy, cellular therapies, and immune therapies, particularly in the treatment of acute myeloid leukaemia and the development of novel therapies to improve patient outcomes.
She obtained her medical degree from University College London and completed her general medical training at St George's Hospital. Her specialist haematology training took place at the Royal Free Hospital and Hammersmith Hospitals in London. Dr Stringaris earned a PhD in Leukaemia from Imperial College London and previously served as a Senior Clinical Lecturer at St Bart’s Hospital.
Her research focuses on immune deficiencies in leukaemia and transplantation immunology. She spent four years as a senior research physician at the National Heart, Lung, and Blood Institute, National Institutes of Health (USA), where she explored natural killer cell immunity and innovative immune therapies for acute myeloid leukaemia.
Appointed as a Consultant Haematologist in 2014, Dr Stringaris is committed to advancing haematology through clinical practice and research. Her expertise includes chemotherapy, cellular therapies, and immune therapies, particularly in the treatment of acute myeloid leukaemia and the development of novel therapies to improve patient outcomes.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Kate Stringaris
Education & training
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Haematology
-
2027–2028 Fellowship · Subspecialty training
Career & appointments
-
2027-09–2028-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Haematology
Malpractice insurance:
Allianz Professional · 4,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,168 |
| Annual physical exam | 99395 | 158 |
| Vaccination administration | 90471 | 2,958 |
| Minor procedure (skin) | 17110 | 361 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 540.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 20 · i10: 8
-
Outcomes of Haematology in adults — a multi-centre cohort
DOI: 10.7961/euroclin.2025.0 · PMID: 33951847 · cited by 16
-
European registry analysis of Haematology outcomes
DOI: 10.9835/euroclin.2024.1 · PMID: 31659649 · cited by 122
-
Outcomes of Haematology in adults — a multi-centre cohort
DOI: 10.4743/euroclin.2023.2 · PMID: 34593327 · cited by 116
-
European registry analysis of Haematology outcomes
DOI: 10.1133/euroclin.2022.3 · PMID: 36599616 · cited by 86
Invited talks
- Practical updates in Haematology European Annual Congress (Haematology) · Vienna · 2024 · invited
- Single-centre experience in Haematology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Haematology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2028
- national college of family doctors — Member · since 2028
- European Union of Medical Specialists (UEMS) — Member · since 2028
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Haematology
- Awareness When should you see a haematology?
For international patients
- Coordinator
- Patient liaison · kate.stringaris@euroclinics.example
